NCI Study Demonstrates Significant Overall Survival and Time-to-Next-Treatment ... MarketWatch (press release) The results (detailed in Abstract #2528), reported in a poster presented by the NCI, demonstrated that vaccination following rituximab combination chemotherapy induced nearly universal T-cell immune responses, the elevation of which strongly correlated ... |
